Attached files

file filename
10-Q - FORM 10-Q - ImmunoCellular Therapeutics, Ltd.d10q.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - ImmunoCellular Therapeutics, Ltd.dex311.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - ImmunoCellular Therapeutics, Ltd.dex322.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - ImmunoCellular Therapeutics, Ltd.dex312.htm

Exhibit 32.1

Certification of the Principal Executive Officer

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ImmunoCellular Therapeutics, Ltd. (the “Company”) hereby certifies that, to his knowledge:

The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 16, 2011   By:  

/s/ Manish Singh

 

Name:  Manish Singh, Ph.D.

Title:    President and Chief Executive Officer